CRT-200.08 Paclitaxel-Eluting Stents in the Superficial Femoral Artery at 12-Month Follow-Up Are Associated With Persistent Inflammation

Previous studies have reported the clinical outcomes of the Zilver PTXTM, a paclitaxel-eluting nitinol stent (Cook® Medical, Bloomington, IN, USA), in patients with de novo or restenotic lesions of the femoropopliteal artery. Intravascular optical coherence tomography (OCT) provides imaging of